We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Kits Available for RNA Isolation from FFPET Samples and for cDNA Preamplification

By LabMedica International staff writers
Posted on 13 Nov 2012
Print article
Image: The High Pure FFPET RNA Isolation Kits (Photo courtesy of Roche).
Image: The High Pure FFPET RNA Isolation Kits (Photo courtesy of Roche).
A new kit will allow genomics researchers to isolate highly purified samples of RNA from FFPET (formalin-fixed, paraffin-embedded tissue) samples for analysis by microarray or for the generation of DNA for PCR studies.

The new High Pure FFPET RNA Isolation Kit was recently placed onto the biotech market by Roche (Basel, Switzerland). This kit was designed for the isolation and purification of total RNA from 5 to 10 micrometer thick sections from FFPET. The isolated RNA is suitable for qRT-PCR (real-time PCR) and microarray analysis.

An investigator using the High Pure FFPET RNA Isolation Kit will require approximately 2.5 hours including the deparaffinization procedure to prepare an RNA sample. The deparaffinized tissue is lysed with special lysis buffers and incubated with Proteinase K. In the presence of chaotropic salts, the RNA is specifically bound to the glass fiber of the kit's High Pure Filter Tube. Bound RNA is then incubated with DNAse and purified in a series of rapid wash-and-spin steps and then eluted from the column. The RNA is recovered without contamination in an elution volume of 25-50 microliters.

The isolated RNA can be analyzed directly, or it may be transcribed into cDNA and subsequently preamplified with Roche's new RealTime Ready cDNA Pre-Amp Master Kit. This kit enables preamplification of minute amounts of cDNA with customized primer pools that correspond to primers that can be applied in subsequent qPCR analysis.

“Our new products provide highly convenient and flexible solutions to researchers who are analyzing gene expression in FFPET samples, while ensuring excellent result quality,” said Gerd Haberhausen, business head of qPCR and sample preparation systems at Roche. “By offering customized, aligned primer sets alongside our new RNA isolation kit, we are able to provide a complete and reliable workflow to scientists investigating the mRNA expression profiles of complex biological pathways.”

Related Links:

Roche


New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HbA1c Test
HbA1c Rapid Test
New
Calprotectin Assay
Fecal Calprotectin ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.